DK656488D0 - Praeparat med langvarig frigivelse indeholdende 1,4-dihydropyridinforbindelser - Google Patents

Praeparat med langvarig frigivelse indeholdende 1,4-dihydropyridinforbindelser

Info

Publication number
DK656488D0
DK656488D0 DK656488A DK656488A DK656488D0 DK 656488 D0 DK656488 D0 DK 656488D0 DK 656488 A DK656488 A DK 656488A DK 656488 A DK656488 A DK 656488A DK 656488 D0 DK656488 D0 DK 656488D0
Authority
DK
Denmark
Prior art keywords
long
preparation containing
release preparation
dihydropyridine compounds
dihydropyridine
Prior art date
Application number
DK656488A
Other languages
English (en)
Other versions
DK656488A (da
Inventor
Madurai Gurusamy Ganesan
Narendra Ragjunathji Desai
Gary Arther Maier
Prakash Shriram Kulkarni
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DK656488D0 publication Critical patent/DK656488D0/da
Publication of DK656488A publication Critical patent/DK656488A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Heat Sensitive Colour Forming Recording (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
DK656488A 1987-11-25 1988-11-24 Praeparat med langvarig frigivelse indeholdende 1,4-dihydropyridinforbindelser DK656488A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12544087A 1987-11-25 1987-11-25

Publications (2)

Publication Number Publication Date
DK656488D0 true DK656488D0 (da) 1988-11-24
DK656488A DK656488A (da) 1989-05-26

Family

ID=22419737

Family Applications (1)

Application Number Title Priority Date Filing Date
DK656488A DK656488A (da) 1987-11-25 1988-11-24 Praeparat med langvarig frigivelse indeholdende 1,4-dihydropyridinforbindelser

Country Status (15)

Country Link
EP (1) EP0317780B1 (da)
JP (1) JPH02655A (da)
KR (1) KR890007746A (da)
AT (1) ATE76292T1 (da)
AU (1) AU626187B2 (da)
DE (1) DE3871343D1 (da)
DK (1) DK656488A (da)
ES (1) ES2037179T3 (da)
FI (1) FI885454A (da)
GR (1) GR3004988T3 (da)
IL (1) IL88197A0 (da)
NO (1) NO885246L (da)
NZ (1) NZ226987A (da)
PT (1) PT89055A (da)
ZA (1) ZA888817B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4117784A1 (de) * 1991-05-31 1992-12-03 Basf Ag Herstellung von protein-polyalkylenglykolkonjugaten
US5834496A (en) * 1991-12-02 1998-11-10 Sepracor, Inc. Methods for treating hypertension using optically pure S(-) felodipine
DE69309452T2 (de) * 1993-06-29 1997-11-06 Heylecina S A Herstellung von aktivierten Carbamaten von Polyalkylenglycol und ihre Verwendung
IE80467B1 (en) * 1995-07-03 1998-07-29 Elan Corp Plc Controlled release formulations for poorly soluble drugs
CA2277220A1 (en) * 1997-01-10 1998-07-16 Abbott Laboratories Tablet for the controlled release of active agents
US6013280A (en) * 1997-10-07 2000-01-11 Fuisz Technologies Ltd. Immediate release dosage forms containing microspheres
SE9704401D0 (sv) * 1997-11-28 1997-11-28 Astra Ab Matrix pellets for greasy, oily or sticky drug substances
US7763769B2 (en) 2001-02-16 2010-07-27 Kci Licensing, Inc. Biocompatible wound dressing
US7700819B2 (en) 2001-02-16 2010-04-20 Kci Licensing, Inc. Biocompatible wound dressing
DK1429126T3 (da) 2002-12-09 2013-03-11 Ishida Seisakusho Kombinationsvægt
US7732467B2 (en) 2003-05-15 2010-06-08 Alzheimer's Institute Of America, Inc. Method for reducing amyloid deposition, amyloid neurotoxicity and microgliosis
CA2561733A1 (en) 2004-04-01 2005-10-13 Cardiome Pharma Corp. Pegylated ion channel modulating compounds
US7705036B2 (en) 2004-04-01 2010-04-27 Cardiome Pharma Corp. Deuterated aminocyclohexyl ether compounds and processes for preparing same
WO2006088525A1 (en) 2004-11-18 2006-08-24 Cardiome Pharma Corp. Synthetic process for aminocyclohexyl ether compounds
CA2612375C (en) 2005-06-15 2013-08-06 Cardiome Pharma Corp. Synthetic processes for the preparation of aminocyclohexyl ether compounds
CA2701620C (en) 2007-10-05 2014-12-09 Alzheimer's Institute Of America, Inc. Method for reducing amyloid deposition, amyloid neurotoxicity, and microgliosis with (-)-nilvadipine enantiomer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA959759A (en) * 1970-01-15 1974-12-24 John J. Miskel Method for absorption of drugs
FR2518403B1 (fr) * 1981-12-22 1987-01-02 Dietlin Francois Procede de preparation de formes pharmaceutiques presentant une resorption par voie digestive amelioree, et les formes pharmaceutiques ainsi obtenues
JPS5989626A (ja) * 1982-09-27 1984-05-23 サンド・アクチエンゲゼルシヤフト ゼンソク予防または処置剤
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device

Also Published As

Publication number Publication date
DK656488A (da) 1989-05-26
ZA888817B (en) 1989-08-30
EP0317780B1 (en) 1992-05-20
DE3871343D1 (de) 1992-06-25
NO885246D0 (no) 1988-11-24
PT89055A (pt) 1989-11-30
AU2587088A (en) 1989-05-25
ATE76292T1 (de) 1992-06-15
AU626187B2 (en) 1992-07-23
NO885246L (no) 1989-05-26
FI885454A (fi) 1989-05-26
GR3004988T3 (da) 1993-04-28
JPH02655A (ja) 1990-01-05
KR890007746A (ko) 1989-07-05
FI885454A0 (fi) 1988-11-24
EP0317780A1 (en) 1989-05-31
IL88197A0 (en) 1989-06-30
ES2037179T3 (es) 1993-06-16
NZ226987A (en) 1992-04-28

Similar Documents

Publication Publication Date Title
DK656488D0 (da) Praeparat med langvarig frigivelse indeholdende 1,4-dihydropyridinforbindelser
PT88603A (pt) Immunomodulatory azapiranes
DK274788A (da) Tetrazoler
PT86648A (pt) Method for the preparation of anti-retroviral compositions containing 3'-azido-2',3'-dideoxyuridine
ES2063829T3 (es) Compuestos.
IT8622434A0 (it) Processo per la preparazione controllata di gilcosaminoglicani a basso peso molecolare.
DE3779461D1 (de) Durch alkylgruppen substituiertes phenylcarbamat von polysaccharid.
DE3887273D1 (de) 2',3'-Dideoxy-2'-fluornucleoside.
ZA883444B (da)
FI881609A0 (fi) Dihydropyridinamider, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
EP0367671A3 (en) Novel beta-d-phenylthioxylosides, their method of preparation and their use as pharmaceuticals
IT1230053B (it) Composizione per l'aumento del guadagno di peso.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment